Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
5-Azacitidine in patients with IDH1/2-mutant recurrent glioma.
Federici L, Capelle L, Annereau M, Bielle F, Willekens C, Dehais C, Laigle-Donadey F, Hoang-Xuan K, Delattre JY, Idbaih A, Lemare F, de Botton S, Sanson M, Touat M. Federici L, et al. Among authors: lemare f. Neuro Oncol. 2020 Aug 17;22(8):1226-1228. doi: 10.1093/neuonc/noaa074. Neuro Oncol. 2020. PMID: 32215616 Free PMC article. No abstract available.
Use of 5-azacitidine for therapy-related myeloid neoplasms in patients with concomitant active neoplastic disease.
Annereau M, Willekens C, El Halabi L, Chahine C, Saada V, Auger N, Danu A, Bermudez E, Lazarovici J, Ghez D, Leary A, Pistilli B, Lemare F, Solary E, de Botton S, Desmaris RP, Micol JB. Annereau M, et al. Among authors: lemare f. Leuk Res. 2017 Apr;55:58-64. doi: 10.1016/j.leukres.2017.01.024. Epub 2017 Jan 20. Leuk Res. 2017. PMID: 28131982
Aprepitant for paediatric chemotherapy-induced nausea and vomiting.
Slimano F, Rigaud C, Annereau M, Gaspar N, Lemare F. Slimano F, et al. Among authors: lemare f. Lancet Oncol. 2015 Jun;16(6):e259. doi: 10.1016/S1470-2045(15)70205-6. Epub 2015 May 27. Lancet Oncol. 2015. PMID: 26065607 No abstract available.
High-dose cyclophosphamide for hard-to-treat patients with relapsed or refractory B-cell non-Hodgkin's lymphoma, a phase II result.
Michot JM, Annereau M, Danu A, Legoupil C, Bertin L, Chahine C, Achab N, Antosikova A, Cerutti A, Rossignol J, Ghez D, Willekens C, Dartigues P, Lazarovici J, Lemare F, Ribrag V. Michot JM, et al. Among authors: lemare f. Eur J Haematol. 2020 Apr;104(4):281-290. doi: 10.1111/ejh.13369. Epub 2020 Jan 28. Eur J Haematol. 2020. PMID: 31838764 Clinical Trial.
ADAM9 expression promotes an aggressive lung adenocarcinoma phenotype.
Kossmann CM, Annereau M, Thomas-Schoemann A, Nicco-Overney C, Chéreau C, Batteux F, Alexandre J, Lemare F. Kossmann CM, et al. Among authors: lemare f. Tumour Biol. 2017 Jul;39(7):1010428317716077. doi: 10.1177/1010428317716077. Tumour Biol. 2017. PMID: 28675123 Free article.
Development of a Hospital Compounded, Taste-Masked, Temozolomide Oral Suspension and 5-Year Real-Life Experience in Treating Paediatric Patients.
Annereau M, Hinterlang M, Bienayme H, Vassal G, Pinon A, Schmitt M, Denis L, Lemarchand C, Martin L, Lemare F, Abbou S, Bastid J, Tortolano L. Annereau M, et al. Among authors: lemare f. Pharmaceuticals (Basel). 2022 Apr 29;15(5):555. doi: 10.3390/ph15050555. Pharmaceuticals (Basel). 2022. PMID: 35631381 Free PMC article.
High incidence of cetuximab-related infusion reactions in head and neck patients.
Palomar Coloma V, Bravo P, Lezghed N, Mayache-Badis L, Herrera Gómez RG, Iacob M, Nicouleau L, Desmaris R, Tao Y, Leibu C, Matias M, Lemare F, Even C, Annereau M, Ferté C. Palomar Coloma V, et al. Among authors: lemare f. ESMO Open. 2018 Jul 23;3(5):e000346. doi: 10.1136/esmoopen-2018-000346. eCollection 2018. ESMO Open. 2018. PMID: 30094066 Free PMC article.
Organoids as preclinical models to improve intraperitoneal chemotherapy effectiveness for colorectal cancer patients with peritoneal metastases: Preclinical models to improve HIPEC.
Roy P, Canet-Jourdan C, Annereau M, Zajac O, Gelli M, Broutin S, Mercier L, Paci A, Lemare F, Ducreux M, Elias D, Malka D, Boige V, Goéré D, Jaulin F. Roy P, et al. Among authors: lemare f. Int J Pharm. 2017 Oct 5;531(1):143-152. doi: 10.1016/j.ijpharm.2017.07.084. Epub 2017 Aug 11. Int J Pharm. 2017. PMID: 28803938
31 results